UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

IL-4-induced macrophage-derived IGF-I protects myofibroblasts from apoptosis following growth factor withdrawal

Journal of leukocyte biology, 2004-11, Vol.76 (5), p.1019-1027

2004

Volltextzugriff (PDF)

OA03.03 Phase 2B of Blueprint PD-L1 Immunohistochemistry Assay Comparability Study

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S325-S325

2018

Volltextzugriff (PDF)

Induction of Macrophage Insulin-Like Growth Factor-I Expression by the Th2 Cytokines IL-4 and IL-13

The Journal of immunology (1950), 2003-10, Vol.171 (7), p.3550-3559

2003

Volltextzugriff (PDF)

P50.05 Natural History and Real-World Treatment Outcomes for NSCLC Patients with EGFR Exon 20 Insertion Mutation: An IASLC- ASCO CancerLinQ Study

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S1116-S1116

2021

Volltextzugriff (PDF)

EP08.01-060 Long term Survival Outcomes in NSCLC Patients with Targeted Therapy and Immunotherapy: An IASLC Analysis of ASCO CancerLinQ Discovery Data

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S368-S369

2022

Volltextzugriff (PDF)

PP01.53 Pathologic Response Assessment Tool – Architecting a Cloud-Based Tool to Streamline Logistics for Shipping, Tracking, Scoring, and Reporting

Journal of thoracic oncology, 2023-03, Vol.18 (3), p.e32-e33

2023

Volltextzugriff (PDF)

Evaluation of the role of mitogen-activated protein kinases in the expression of inducible nitric oxide synthase by IFN-gamma and TNF-alpha in mouse macrophages

The Journal of immunology (1950), 1999-01, Vol.162 (1), p.415-422

1999

Volltextzugriff (PDF)

P1.02-02 Current Status, Challenges and Perspectives of Lung Cancer Screening in Low- and Middle-Income Countries

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S98-S99

2022

Volltextzugriff (PDF)

MA11.07 The ELIC Distributed Database and Computation Environment for Analyses of Lung Cancer Screening LDCTs Across the World

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S82

2022

Volltextzugriff (PDF)

EP01.04-005 Quantitative Characteristics in Global CT Lung Cancer Screening Populations Using the ELIC Distributed Database and Computation Environment

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S180-S181

2022

Volltextzugriff (PDF)

PP01.39 Infrastructure for Interobserver Variability Assessment of Pathologic Response (PR), in Surgical Resection Specimens Following Neoadjuvant Immune Check Point Inhibitor (ICI) Therapies in Early Stage NSCLC

Journal of thoracic oncology, 2023-03, Vol.18 (3), p.e26-e27

2023

Volltextzugriff (PDF)

MA21.03 The International Association for the Study of Lung Cancer (IASLC) Global Survey on Molecular Testing in Lung Cancer

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S335-S336

2019

Volltextzugriff (PDF)

OA01.09 Comparing Regional Results from the IASLC Global Survey on Molecular Testing in Lung Cancer

Journal of thoracic oncology, 2019-11, Vol.14 (11), p.S1127-S1127

2019

Volltextzugriff (PDF)

Preferential Activation of the p46 Isoform of JNK/SAPK in Mouse Macrophages by TNFα

Proceedings of the National Academy of Sciences - PNAS, 1997-11, Vol.94 (24), p.13169-13174

1997

Volltextzugriff (PDF)

O.04 Results from the IASLC Global Survey on Molecular Testing in Lung Cancer

Journal of thoracic oncology, 2019-11, Vol.14 (11), p.S1153-S1154

2019

Volltextzugriff (PDF)

P2.09-24 IASLC Global Survey for Pathologists on PD-L1 Testing for Non-Small Cell Lung Cancer

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S778-S779

2019

Volltextzugriff (PDF)

Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer

Journal of thoracic oncology, 2018-12, Vol.13 (12), p.1818-1831

2018

Volltextzugriff (PDF)

Phase 2B of Blueprint PD-L1 Immunohistochemistry Assay Comparability Study

Journal of thoracic oncology, 2018, Vol.13 (10), p.S325

2018

Volltextzugriff (PDF)

Predictive value of thymidylate synthase and folylpoly-glutamate synthetase for clinical benefit from pemetrexed in malignant pleural mesothelioma

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.7024-7024

2011

Volltextzugriff (PDF)

Thymidylate synthase (TS) gene copy number in NSCLC

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e21063-e21063

2010

Volltextzugriff (PDF)

Immunohistochemistry detection of epidermal growth factor receptor (EGFR) exons 19 and 21 mutations in non-small cell lung cancer (NSCLC) using novel mutation specific antibodies

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.10542-10542

2010

Volltextzugriff (PDF)

Protein expression (PE) and increased IGF1R gene copy number (GCN) in small cell lung cancer (SCLC)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.10584-10584

2010

Volltextzugriff (PDF)

The role of IGF-1R in EGFR TKI resistance in NSCLC using IHC and AQUA technology

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.10556-10556

2011

Volltextzugriff (PDF)

Analysis of IGF1R gene copy number by silver in situ hybridization (SISH) in non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.7525-7525

2009

Volltextzugriff (PDF)

Regulation of Chemokine Expression by NaCl Occurs Independently of Cystic Fibrosis Transmembrane Conductance Regulator in Macrophages

The American journal of pathology, 2006-07, Vol.169 (1), p.12-20

2006

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(71)

Publikationsform

Artikel
(75)
Reviews
(4)
Bücher
(1)
Berichte
(1)

Sprache

Englisch
(81)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

IL-4-induced macrophage-derived IGF-I protects myofibroblasts from apoptosis following growth factor withdrawal

OA03.03 Phase 2B of Blueprint PD-L1 Immunohistochemistry Assay Comparability Study

Induction of Macrophage Insulin-Like Growth Factor-I Expression by the Th2 Cytokines IL-4 and IL-13

P50.05 Natural History and Real-World Treatment Outcomes for NSCLC Patients with EGFR Exon 20 Insertion Mutation: An IASLC- ASCO CancerLinQ Study

EP08.01-060 Long term Survival Outcomes in NSCLC Patients with Targeted Therapy and Immunotherapy: An IASLC Analysis of ASCO CancerLinQ Discovery Data

PP01.53 Pathologic Response Assessment Tool – Architecting a Cloud-Based Tool to Streamline Logistics for Shipping, Tracking, Scoring, and Reporting

Evaluation of the role of mitogen-activated protein kinases in the expression of inducible nitric oxide synthase by IFN-gamma and TNF-alpha in mouse macrophages

P1.02-02 Current Status, Challenges and Perspectives of Lung Cancer Screening in Low- and Middle-Income Countries

MA11.07 The ELIC Distributed Database and Computation Environment for Analyses of Lung Cancer Screening LDCTs Across the World

EP01.04-005 Quantitative Characteristics in Global CT Lung Cancer Screening Populations Using the ELIC Distributed Database and Computation Environment

PP01.39 Infrastructure for Interobserver Variability Assessment of Pathologic Response (PR), in Surgical Resection Specimens Following Neoadjuvant Immune Check Point Inhibitor (ICI) Therapies in Early Stage NSCLC

MA21.03 The International Association for the Study of Lung Cancer (IASLC) Global Survey on Molecular Testing in Lung Cancer

OA01.09 Comparing Regional Results from the IASLC Global Survey on Molecular Testing in Lung Cancer

Preferential Activation of the p46 Isoform of JNK/SAPK in Mouse Macrophages by TNFα

O.04 Results from the IASLC Global Survey on Molecular Testing in Lung Cancer

P2.09-24 IASLC Global Survey for Pathologists on PD-L1 Testing for Non-Small Cell Lung Cancer

Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer

Phase 2B of Blueprint PD-L1 Immunohistochemistry Assay Comparability Study

Predictive value of thymidylate synthase and folylpoly-glutamate synthetase for clinical benefit from pemetrexed in malignant pleural mesothelioma

Thymidylate synthase (TS) gene copy number in NSCLC

Immunohistochemistry detection of epidermal growth factor receptor (EGFR) exons 19 and 21 mutations in non-small cell lung cancer (NSCLC) using novel mutation specific antibodies

Protein expression (PE) and increased IGF1R gene copy number (GCN) in small cell lung cancer (SCLC)

The role of IGF-1R in EGFR TKI resistance in NSCLC using IHC and AQUA technology

Analysis of IGF1R gene copy number by silver in situ hybridization (SISH) in non-small cell lung cancer (NSCLC)

Regulation of Chemokine Expression by NaCl Occurs Independently of Cystic Fibrosis Transmembrane Conductance Regulator in Macrophages

Suchergebnisse filtern